KENIRAX-DX
KENIRAX-DX is a pharmaceutical cough syrup formulation containing Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate. The product packaging specifies the strengths as 15 mg, 5 mg and 2 mg respectively, while the product documentation confirms the same three active ingredients in the formulation.
Dextromethorphan Hydrobromide is a centrally acting cough suppressant, Chlorpheniramine Maleate is an antihistamine, and Phenylephrine Hydrochloride is a decongestant. Together, these active pharmaceutical ingredients form a multi-component oral liquid formulation within the Cough Syrup segment of the Suprimeda pharmaceutical portfolio.
KENIRAX-DX is presented as a 100 ml oral syrup, providing a defined liquid dosage form for professional pharmaceutical cataloguing and institutional procurement. The formulation can be identified using relevant pharmaceutical search terms including KENIRAX-DX syrup, cough syrup, Dextromethorphan syrup, Phenylephrine syrup, Chlorpheniramine syrup and combination cough syrup.
Everything You, Need to Know
KENIRAX-DX is available in a 100 ml bottle.
KENIRAX-DX is available as an oral syrup formulation.
KENIRAX-DX contains Dextromethorphan Hydrobromide 15 mg, Phenylephrine Hydrochloride 5 mg and Chlorpheniramine Maleate 2 mg.